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ORIGINAL STUDY
Syringomatous Structures in Extramammary PagetDisease:
A Potential Diagnostic Pitfall
Anastasia M. Konstantinova, MD, PhD,*† Malcolm M. Hayes, MB, MMed (Anat Path), FRCPath,‡
Colin J. R. Stewart, FRCPA,§ Jose A. Plaza, MD,¶ Michal Michal, MD,k** Katrin Kerl, MD,††
and Dmitry V. Kazakov, MD, PhD**††
Abstract: Primary extramammary Paget disease (EMPD) is a form
of intraepithelial adenocarcinoma. Different morphological changes
may accompany EMPD, including the presence of syringoma-like
structures. The authors report 10 cases of EMPD, all of which
manifested syringoma-like structures within the dermis both in areas
involved by the carcinoma and beyond, including at the margins of the
excisions. All patients were women, whose ages ranged from 49 to 93
years (median 75 years). The possible pathogenesis of the syringoma-
like lesions is discussed. Awareness of these structures in vulvectomy
specimens for EMPD is important to prevent misinterpretation of the
syringoma-like lesions as an invasive component of the EMPD.
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INTRODUCTION
Primary extramammary Paget disease (EMPD) is a form
of intraepithelial adenocarcinoma of uncertain histogenesis.
Various origins have been proposed including apocrine
glands, eccrine glands, hair follicles,1–8 anogenital
mammary-like glands, Toker cells, or pluripotential stem cells
in the epidermis.9–14 Unlike mammary Paget disease, EMPD
is seldom associated with an underlying ductal carcinoma in
situ or invasive carcinoma except for those cases that arise
within an anogenital mammary-like glands.15–18 In contrast,
syringoma is a benign adnexal neoplasm occurring in the
superﬁcial dermis.19 Both lesions occur on the vulva and
perineal skin but, there is no known relationship between
them. In the vulva, syringomas are often associated with
chronic pruritis, also a common symptom of EMPD.20,21
During histopathological examination of vulvectomy
specimens from 10 patients with EMPD we encountered
small syringoma-like foci in the dermis beneath the involved
epidermis and occasionally beyond the margin of the EMPD.
Our study is focused on these unusual glandular structures,
which could be interpreted as invasive carcinoma and
therefore represent a diagnostic pitfall for pathologists
unaware of their existence.
MATERIALS AND METHODS
The 10 patients constituting the subject of this report
were found among 98 cases of EMPD in the joint
consultation and institutional ﬁles of the authors. Clinical
information was obtained from the patients’ physicians and
from review of case records. Each case was stained with
hematoxylin and eosin and mucicarmine, and immunohis-
tochemical staining for CK7 and p63 was performed on 9
blocks from 7 patients.
In 3 cases, syringomatous change was seen both in the
initial biopsy and in subsequent specimens demonstrating
local recurrence of the EMPD. A total of 13 specimens were
examined comprising 10 vulvectomies with the number of
tissue blocks ranging from 14 to 27, and 3 wide local
excisions sampled in 4, 13, and 18 blocks, respectively.
Overall, syringomatous structures were recognized in 31 of
247 blocks studied (Table 1).
CLINICAL DATA
All patients were women whose ages ranged from 49
to 93 years. Eight patients presented with a newly diag-
nosed EMPD, whereas the other 2 had a previous history of
EMPD treated by various modalities (Table 1). All patients
clinically manifested ﬂat or slightly elevated erythematous
or white-gray areas, with some scaling, excoriations, and
crust consistent with primary EMPD (Fig. 1). In 1 patient,
small papules were present within and outside the affected
areas, but these proved to be infundibular cysts on histol-
ogy. None of the patients had had a history of a carcinoma
in the urogenital or gastrointestinal tract that might have
suggested secondary skin involvement from these sites.
One patient had a history of vulvar squamous cell
carcinoma.
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MICROSCOPIC FEATURES
The typical microscopic features of EMPD were present
in all cases. These included an intraepithelial spread of cells
with ample cytoplasm distributed singly and in small clusters.
In all cases, small gland-like elements formed by the neoplastic
cells were identiﬁed within the epidermis. In 2 cases, malignant
glandular elements were seen lying free in the upper dermis
consistent with microinvasion. Apart from these neoplastic
glandular elements, all cases showed benign-looking dermal
ductal structures resembling classical syringoma (Fig. 2). These
syringomatous foci were present both beneath the areas
affected by the EMPD and outside them, sometimes being
noted in sections taken from the margins of excision. The
syringomatous structures appeared as a cluster of benign look-
ing ductal elements with attenuated epithelium, including focal
tadpole-like appearances. Their connection to an eccrine secre-
tory unit could be traced on serial sections (Fig. 3). In 1 case,
syringomatous ducts were embedded within a dense sclerotic
stroma imparting the appearance of an authentic incipient sy-
ringoma. This case also showed multifocal (2–3 foci) syrin-
gomatous lesions. In 1 case, syringomatous structures were
colonized by the neoplastic cells from the EMPD (Fig. 4).
On immuhistochemical staining, syringoma-like struc-
tures were identiﬁed in 6 blocks from 4 patients. Staining for
p63 highlighted the preserved native cells in the basal layer of
the epidermis and in syringoma-like structures (Fig. 5A).
Staining for CK7 revealed neoplastic cells, although the
syringoma-like structures were negative (Fig. 5B).
DISCUSSION
Although glandular and pseudoglandular formations are
well known features of EMPD, syringomatous structures in
this condition have seldom been mentioned in the literature.
Requena et al22 in their monograph on apocrine tumors of the
skin in ﬁgure 38.10 document glandular elements naming
them syringomatous structures. However, to our eyes, those
glandular elements more likely represent neoplastic glands
with an attenuated epithelial lining rather than a benign
syringomatous lesion. The syringomatous structures we
describe are different. Most seem to represent hyperplasia
(and dilatation) of preexisting eccrine ducts, as these were
clustered, and a connection to eccrine secretory lobules could
be followed on serial sections. In 1 case, the syringomatous
TABLE 1. Main Clinical Features of the Patients
Case No Sex/Age Clinical Data and Follow-up Tissue Blocks*
Location of Syringomatous
Structures
1 F/75 NED at 57 mo 2/17 Beneath AA (·2)
2 F/75 Recurrence treated with second excision at 20 mo
and second recurrence with invasive
adenocarcinoma at 101 mo
3/27 Beneath AA (·1)
Outside AA (·2)
6/23 Beneath AA (·5)
Outside AA (·1)
3 F/60 NED at 34 mo 1/25 Beneath AA (·1)
4 F/80 Four recurrences in next 74 mo. Further treatment
refused
1/19 Beneath AA (·1)
2/23 Beneath AA (·2)
5 F/84 Wide local excision (up to 70 · 18 mm in size).
Recurrence in 3 yrs and diagnosis of breast
carcinoma at the same time. No further treatment
for EMPD (refused by patient). DUC 5 yrs later
1/18 Beneath AA (·1)
1/21 Beneath AA (·1)
6 F/81 One-year history of EMPD treated with wide local
excision. NED at 60 mo
1/4 Beneath AA (·1)
7 F/93 Previous resection of squamous cell carcinoma of the
vulva. Review at 2 mo, probable residual EMPD.
Patient refused further treatment. DUC at 13 mo
1/17 Beneath AA (·1) Pagetoid spread
along syringomatous structures
8 F/49 NED at 62 mo 8/14 Multifocal in 3 blocks all beneath
AA (·8)
9 F/74 NED at 60 mo 1/20 Beneath AA (·1)
10 F/65 Wide local excision (70 · 32 mm in size). AWD
(metastases to supraclavicular and inguinal lymph
nodes)
3/13 Beneath AA (·3)
NED no evidence of disease.
AWD alive with disease.
DUC death of unknown (case 5) or unrelated (case 7) cause.
AA areas affected by the EMPD.
*The ﬁrst number indicates the number of tissue blocks in which the syringomatous structures were identiﬁed. The number after slash indicates the total number of blocks available
from case.
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glands were embedded within a dense sclerotic stroma and
the appearance was highly reminiscent of a small syringoma.
Similar syringoma-like ductal proliferations are rarely found
in different types of alopecia, especially scarring alopecia, but
these are usually very small, focal, and are devoid of the
typical sclerotic stroma that characterizes true syringoma.
Although initially believed to represent true syringomas caus-
ing alopecia, these ductal proliferations were later presumed
to be a reactive process secondary to the surrounding inﬂam-
mation and dermal ﬁbrosis.23–27 It has been suggested that
these ductal proliferations are the result of destruction of
the acrosyringium by lymphoid inﬁltration (“autoimmune
acrosyringitis”) resulting in loss of structural continuity of
the acrosyringium followed by secondary proliferation of
the disrupted ducts.28 Other inﬂammatory and neoplastic con-
ditions in which syringomatous ductal proliferations have
been reported include Grover disease, leukemia cutis, prior
irradiation, reexcision specimens, and prurigo nodularis.29–32
We presume that persistent rubbing, excoriation, and block-
age of the intraepidermal acrosyringia by the EMPD may all
contribute to the disruption and secondary hyperplasia/dilata-
tion of eccrine ducts to form syringomatous structures.
FIGURE 1. Clinical appearance of
EMPD: Erythematous erosive areas
(A, case 8. B, case 3). Note small
papules within the affected area and
on normal skin (B). Histopathologi-
cally these represented infundibular
cysts.
FIGURE 2. Syringoma-like structures in EMPD: Small ductal
structures lined by bland-looking epithelial cells. Note tadpole-
like appearances and sclerotic stroma reminiscent of syringo-
ma. Intraepidermal carcinoma cells are evident above the
lesion.
FIGURE 3. Connection of syringomatous structures to an ec-
crine secretory unit suggests that these may represent hyper-
plastic and dilated eccrine ducts.
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Whatever their pathogenesis, the syringomatous struc-
tures in EMPD represent a diagnostic pitfall, which is actually
2-fold. First, they should not be mistaken for true invasive
neoplastic glandular elements. However, as demonstrated by
our case 7, these syringomatous glands may themselves be
colonized by the neoplastic cells from the EMPD and perhaps
serve as a conduit for the malignant cells to spread into the
deeper regions of the dermis. Adnexotropism of neoplastic
cells in EMPD is well known.10 In some cases of EMPD, we
observed foci in which the neoplastic cells invaded the stroma
from involved adnexal structures (hair follicles, apocrine, and
eccrine glands) deep in the dermis. This pattern contrasts with
the type of microinvasion deﬁned by Feuer et al33 who
described invasion by the neoplastic elements to a depth of
no more than 1 mm below the basement membrane of the
surface epithelium. Such invasion from involved adnexal
structures is similar to the pattern seen in carcinoma of the
cervix, where microinvasion from involved endocervical
glands is not uncommon.
The spectrum of EMPD includes cytologic variations in
the neoplastic cells, single cell distribution and nested patterns,
proliferative epidermal lesions, syringocystadenocarcinoma
papilliferum in situ like areas, and hyperpigmented forms,
rarely with melanocytic hyperplasia.16,21 A single case of EMPD
with oncocytic changes has been described.34 The syringoma-
like structures reported here extend the morphological spectrum
FIGURE 4. Involvement of syringomatous structures by
neoplastic cells (arrows).
FIGURE 5. p63 and CK7 im-
munostaining of syringoma-like
structures in EMPD. A, Staining for
p63 highlights the preserved native
cells in the basal layer of the epi-
dermis and in syringoma-like struc-
tures. B, Staining for CK7 reveals
neoplastic cells while syringoma-like
structures are negative.
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of EMPD, and awareness of these structures is important to
avoid their misinterpretation as an invasive component of the
carcinoma.
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